Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans.

Frontiers in Microbiology
Rui YuanNa Liu

Abstract

Candida albicans is the most common fungal pathogen. Recently, drug resistance of C. albicans is increasingly severe. Hsp90 is a promising antifungal target to overcome this problem. To evaluate the effects of Hsp90 inhibitor ganetespib on the inhibition of azole-resistant C. albicans, the microdilution checkerboard method was used to measure the in vitro synergistic efficacy of ganetespib. The XTT/menadione reduction assay, microscopic observation, and Rh6G efflux assay were established to investigate the effects of ganetespib on azole-resistant C. albicans biofilm formation, filamentation, and efflux pump. Real-time RT-PCR analysis was employed to clarify the mechanism of antagonizing drug resistance. The in vivo antifungal efficacy of ganetespib was determined by the infectious model of azole-resistant C. albicans. Ganetespib showed an excellent synergistic antifungal activity in vitro and significantly inhibited the fungal biofilm formation, whereas it had no inhibitory effect on fungal hypha formation. Expression of azole-targeting enzyme gene ERG11 and efflux pump genes CDR1, CDR2, and MDR1 was significantly down-regulated when ganetespib was used in combination with FLC. In a mouse model infected with FLC-resistant C. al...Continue Reading

References

Jul 17, 2004·Molecular Microbiology·Mary T KellyGeraldine Butler
Feb 28, 2006·Revista iberoamericana de micología·Frank C Odds
Jul 15, 2006·PLoS Pathogens·Clarissa J NobileAaron P Mitchell
Oct 13, 2006·Eukaryotic Cell·Clarissa J NobileAaron P Mitchell
Jun 17, 2009·PLoS Biology·Clarissa J NobileAaron P Mitchell
Dec 1, 2010·Eukaryotic Cell·Yaoping Liu, Scott G Filler
Jan 29, 2011·The Lancet Infectious Diseases·Marisa H MiceliSamuel A Lee
Dec 21, 2012·Science Translational Medicine·Gordon D BrownTheodore C White
Apr 17, 2013·Current Opinion in Microbiology·Leah E Cowen
Jun 29, 2013·Biomedical Journal·Jing Li, Johannes Buchner
Jan 1, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Cuenca-Estrella
Mar 5, 2014·Journal of Medicinal Chemistry·Maurizio TaddeiWalter Cabri
Mar 19, 2015·Journal of the American Chemical Society·Changwook LeeByoung Heon Kang
Mar 31, 2015·Science·David W Denning, Michael J Bromley
Feb 18, 2016·Biotechnology Research International·Shraddha TiwariJata Shankar
Jun 9, 2016·Virulence·Taissa VilaJosé L Lopez-Ribot
Jul 5, 2016·Advanced Biomedical Research·Shahla RoudbarmohammadiMehraban Falahati
Oct 9, 2016·Trends in Microbiology·Daniela AraújoSónia Silva
Nov 12, 2016·Methods in Molecular Biology·David A EnochChristianne Micallef
Jan 5, 2017·Journal of Medicinal Chemistry·Shanchao WuChunquan Sheng
May 13, 2017·Nature Reviews. Drug Discovery·John R Perfect
Sep 16, 2017·The Journal of Infectious Diseases·Maiken Cavling Arendrup, Thomas F Patterson
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Matteo BassettiOliver A Cornely
Mar 17, 2018·Current Opinion in Microbiology·Nicole M RevieLeah E Cowen
Jun 14, 2018·Frontiers in Microbiology·João Oliveira-PachecoPaula Sampaio
Jan 27, 2019·Nature Communications·Luke WhitesellLeah E Cowen
Sep 13, 2019·Journal of Medicinal Chemistry·David S HuangLauren E Brown
May 23, 2020·Chemical Reviews·Yunjin LeeLeah E Cowen

❮ Previous
Next ❯

Software Mentioned

PyMol

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.